According to SELLAS Life Sciences CEO Angelos Stergiou, his company is close to finalizing a leukemia vaccine, but the potential for personalized cancer vaccines using artificial intelligence is on the horizon.
“I believe that the next decade will bring revolutionary advancements in medicine and clinical research,” he stated during an interview on “Fox & Friends.”
“AI will enable us to work more efficiently and provide personalized treatments. For example, by using AI to analyze a patient’s genomic sequencing, we can create a customized vaccine or treatment that is tailored to the individual.”
AI-DESIGNED DRUG FOR INFLAMMATORY BOWEL DISEASE ENTERS HUMAN CLINICAL TRIALS: ‘A SIGNIFICANT NEED’
A.I. is expected to revolutionize treatments for cancer within the next few years. (iStock)
Dr. Stergiou estimates that specialized vaccines could be developed within the next three to four years.
“It’s crucial to note that the quality of data input will directly impact the results of the algorithm, so it will require significant effort from the medical community to ensure accurate data interpretation,” he added.
AI expert Mark Beckman, author of “Some Future Day,” also joined the interview on “Fox & Friends,” referring to the AI era as the “age of imagination.”
AI COULD PREDICT WHETHER CANCER TREATMENTS WILL WORK, EXPERTS SAY: ‘EXCITING TIME IN MEDICINE’
During the discussion, Beckman highlighted Google’s new AI research system, AMIE, which focuses on identifying rare illnesses and supporting physicians in diagnosis.
CLICK HERE TO GET THE FOX NEWS APP
